97228 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
IgE antibodies to chimeric or humanized IgG therapeutic monoclonal antibodies as a screening test for anaphylaxis
#302Atopic dermatitis inducer
#303Compositions and methods for treating IgE-mediated disorders
#304POLYPEPTIDE CONSTRUCTS FOR SUBLINGUAL ADMINISTRATION
#305Genetically Altered Anti-body Producing Cell Lines With Improved Antibody Characteristics
#306Polypeptide constructs including VHH directed against EGFR for intracellular delivery
#307SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR
#308POLYPEPTIDE CONSTRUCTS FOR TOPICAL ADMINISTRATION
#309POLYPEPTIDE CONSTRUCTS FOR RECTAL AND/OR VAGINAL ADMINISTRATION
#310POLYPEPTIDE CONSTRUCTS FOR NASAL ADMINISTRATION
#311HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS
#312Stabilized single domain antibodies
#313Aptameric IgE peptides in a protein scaffold as an allergy vaccine
#314Methods to treating chronic obstructive pulmonary disease
#315IMMUNOGLOBULIN ASSOCIATED CELL-SURFACE DETERMINANTS IN THE TREATMENT OF B-CELL DISORDERS
#316PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF
#317ALLERGY VACCINES
#318Fc variants with altered binding to FcRn
#319Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#320Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells
#321Anti-IgE antibodies
#322Antibodies and methods for generating genetically altered antibodies with enhanced effector function
#323Optimized Fc variants and methods for their generation
#324Methods for Treatment of Allergic Asthma
#325Optimized Fc variants and methods for their generation
#326Optimized Fc variants and methods for their generation
#327Binding members for IgE molecules
#328Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
#329Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy
#330Apoptotic anti-IgE antibodies
#331Polypeptide variants with altered effector function
#332Polypeptide variants with altered effector function
#333Molecular antigen arrary
#334POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION
#335Polypeptide variants with altered effector function
#336Bi-specific complexes for targeting cells involved in allergic-type reactions, compositions and uses thereof
#337Human Antibodies And Proteins
#338Antibodies and methods for making and using them
#339Polypeptide variants
#340Modified plant viruses and methods of use thereof
#341Conjugate and its use as a standard in an immunoassay
#342Anti-IgE Vaccines
#343GLYCOPROTEIN COMPOSITIONS
#344Method For The Removal Of Aggregate Proteins From Recombinant Samples Using Ion Exchange Chromatography
#345Anti-IgE antibodies
#346Antibodies and methods for generating genetically altered antibodies with high affinity
#347Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
#348Process for Concentration of Antibodies and Therapeutic Products Thereof
#349Stabilized single domain antibodies
#350Immunoglobulin E detection in mammalian species
#351Fraction comprising guinea pig immunoglobulin e and antibody
#352Feline immunoglobulin E molecules and related methods
#353Methods and compositions for increasing antibody production
#354Antigen arrays for treatment of bone disease
#355Non-Human Primate Fc Receptors and Methods of Use
#356Antigen arrays for treatment of allergic eosinophilic diseases
#357Angiotensin peptide-carrier conjugates and uses thereof
#358Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
#359Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
#360Prokaryotically produced antibodies and uses thereof
#361Expression Vectors and Methods
#362HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS
#363Molecular antigen array
#364Expression Vectors and Methods
#365Prokaryotically produced antibodies and uses thereof
#366GLYCOPROTEIN COMPOSITIONS
#367Immunoglobulin variants
#368METHODS FOR TREATMENT OF ALLERGIC ASTHMA
#369Polypeptide variants with altered effector function
#370Protein formulation
#371High affinity anti-human IgE antibodies
#372Method for generating high affinity antibodies
#373Polypeptide variants with altered effector function
#374Polypeptide variants
#375Polypeptide variants with altered effector function
#376Polypeptide variants with altered effector function
#377Atopic dermatitis inducer
#378Stable liquid formulations of antibodies
#379CDR-repaired antibodies
#380Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
#381Treating a mammal with a formulation comprising an antibody which binds IgE
#382Angiotensin peptide-carrier conjugates and uses thereof
#383Polypeptide variants with altered effector function
#384Process for concentration of antibodies and therapeutic products thereof
#385Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
#386Methods of treating IgE-associated disorders and compositions for use therein
#387Peptide composition as immunogen for the treatment of allergy
#388Polypeptide variants with altered effector function
#389Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
#390Immunoglobulin E detection in mammalian species
#391Prokaryotically produced antibodies and use thereof
#392Identification of novel IgE epitopes
#393Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
#394Polypeptide variants with altered effector function
#395Methods and compositions for the treatment of infertility using dilute hormone solutions
#396Nucleic acid encoding anti-IgE antibodies
#397Antibodies and methods for generating genetically altered antibodies with enhanced effector function
#398Non-human primate Fc receptors and methods of use
#399Genetically altered antibody-producing cell lines with improved antibody characteristics
#400Methods and compositions for increasing antibody production
#401Compositions for use in treating ige-associated disorders
#402Methods of prevention and treatment of asthma, and allergic conditions
#403Methods of prevention and treatment of asthama, and allergic conditions
#404Methods of prevention and treatment of asthma, and allergic conditions
#405Expression vectors and methods
#406Anti-IgE antibody therapy for multiple food allergies